{"prompt": "['Novartis', 'Confidential', 'Page 6', 'Amended Protocol Version 03 (Clean)', 'Protocol No. CQAW039A2322', 'Table 16-1', 'Liver Event and Laboratory Trigger Definitions', '67', 'Table 16-2', 'Follow Up Requirements for Liver Events and Laboratory Triggers 67', 'Table 16-3', 'Specific Renal Alert Criteria and Actions', '69', 'List of figures', 'Figure 3-1', 'Study Schematic', '20', 'Figure 12-1', 'Representation of Approach to Test Hypotheses', '56', 'Figure 16-1', 'Nasal Congestion Score', '70', 'Figure 16-2', 'SNOT-22 Questionnaire', '71', 'Figure 16-3', 'Asthma Control Questionnaire - 5 - Page 1', '72', 'Figure 16-4', 'Asthma Control Questionnaire - 5 - Page 2', '73']['Novartis', 'Confidential', 'Page 7', 'Amended Protocol Version 03 (Clean)', 'Protocol No. CQAW039A2322', 'List of abbreviations', 'ACQ-5', 'asthma control questionnaire - 5 questions', 'ACR', 'albumin-creatinine ratio', 'ADME', 'absorption, distribution, metabolism, excretion', 'AE', 'adverse event', 'AESI', 'adverse event of special interest', 'Alb', 'albumin', 'ALP', 'alkaline phosphatase', 'ALT', 'alanine aminotransferase', 'APTT', 'activated partial thromboplastin time', 'AST', 'aspartate aminotransferase', 'ATC', 'anatomical therapeutic chemical', 'AUC', 'area under the curve', 'AV', 'atrioventricular', 'BMI', 'body mass index', 'BSACI', 'British society for allergy and clinical immunology', 'BUN', 'blood urea nitrogen', 'CFR', 'code of federal regulation', 'CK', 'creatinine kinase', 'Cmax', 'maximum concentration', 'COAs', 'clinical outcome assessments', 'CPO', 'country pharma organisation', 'CRA', 'clinical research associate', 'CRF', 'case report/record form (paper or electronic)', 'CT', 'computerized tomography', 'CTT', 'clinical trial team', 'DAR', 'dose administration record', 'DMC', 'data monitoring committee', 'DP2', 'prostaglandin D2 receptor', 'EC', 'ethics committee', 'ECG', 'electrocardiogram', 'eCRF', 'electronic case report form', 'EDC', 'electronic data capture', 'eGFR', 'estimated glomerular filtration rate', 'EMA', 'European medicines agency', 'ENT', 'ear, nose, throat', 'EOT', 'end of treatment', 'EU', 'European Union', 'FAS', 'full analysis sets', 'FCT', 'film-coated tablets', 'FEV1', 'forced expiratory volume in 1 second', 'FVC', 'forced vital capacity']['Novartis', 'Confidential', 'Page 8', 'Amended Protocol Version 03 (Clean)', 'Protocol No. CQAW039A2322', 'GCP', 'good clinical practice', 'GGT', 'gamma-glutamyl-transferase', 'GINA', 'global initiative for asthma', 'HbA1c', 'hemoglobin A1c', 'IB', \"Investigator's brochure\", 'ICH', 'international conference on harmonization of technical requirements for registration of', 'pharmaceuticals for human use', 'ICS', 'inhaled corticosteroids', 'IDR', 'idiosyncratic drug reactions', 'IEC', 'independent ethics committee', 'IgE', 'immunoglobulin E', 'IL5', 'interleukin 5', 'ILC2', 'innate lymphoid cell type 2', 'IN', 'Investigator notification', 'INR', 'international normalized ratio', 'IRB', 'institutional review board', 'IRT', 'interactive response technology', 'IUD', 'intrauterine device', 'IUS', 'intrauterine system', 'LABA', 'long-acting bronchodilator', 'LAMA', 'long-acting muscarinic antagonist', 'LDH', 'lactate dehydrogenase', 'LFT', 'liver function test', 'LOCF', 'last observation carried forward', 'LTRA', 'leukotriene receptor antagonist', 'MAR', 'missing at random', 'MCH', 'mean corpuscular hemoglobin', 'MCHC', 'mean corpuscular hemoglobin concentration', 'MCV', 'mean corpuscular volume', 'MDRD', 'modification of diet in renal disease', 'MedDRA', 'Medical dictionary for regulatory activities', 'MFS', 'mometasone furoate nasal spray', 'MMRM', 'mixed model repeated measures', 'MXR', 'multixenobiotic resistance', 'NCS', 'nasal congestion score', 'NIMP', 'non-investigational medicinal product', 'NP', 'nasal polyposis', 'NPS', 'nasal polyp score', 'NYHA', 'New York Heart Association', 'OAT', 'organic anion transporter', 'OATP', 'organic anion transporting polypeptide', 'OCS', 'oral corticosteroids']\n\n###\n\n", "completion": "END"}